2-Bromofluorobenzene | CAS:1072-85-1

We serve 2-Bromofluorobenzene CAS:1072-85-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Bromofluorobenzene

Chemical Name:2-Bromofluorobenzene
CAS.NO:1072-85-1
Synonyms:2-Bromofluorobenzene
1,2-Fluorobromobenzene
2-Fluorobromobenzene
ortho-fluorobromobenzene
1-bromo-2-fluorobenzene
2-fluoro-bromobenzene
Molecular Formula:C6H4BrF
Molecular Weight:174.99800
 
Physical and Chemical Properties:
Density:1.601
Melting point:-8ºC
Boiling point:78-82ºC
Flash point:110°F
Index of Refraction:1.534
 
Specification:
Appearance:Yellow transparent liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 2-Bromofluorobenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-fluoro-bromobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-fluoro-bromobenzene Use and application,2-Fluorobromobenzene technical grade,usp/ep/jp grade.


Related News: Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.Polysiloxanes di-Me Me hydrogen manufacturer Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.1,4-dichlorobenzene supplier The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself.3-Chloromethyl-benzotrifluoride vendor Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData’s Company Financials database.